Management of Bladder Cancer: A Comprehensive Text with Clinical Scenarios

Description: Management of bladder cancer provides a single, comprehensive reference source that incorporates all the latest information regarding bladder cancer. The text covers epidemiology and natural history of bladder cancer as well as latest findings regarding the genetics and molecular biology of the disease. Diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer is discussed. The text incorporates chapters summarizing new findings regarding markers for the diagnosis of bladder cancer and new diagnostic techniques to enhance traditional methods such as cystoscopy. Risk stratified treatment of non muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. The application of chemotherapy for muscle invasive and advanced disease is discussed and the evidence based application of multimodality therapy highlighted. Finally, gaps in current knowledge and areas for future research are highlighted. Ongoing important clinical trials which could imminently yield significant new knowledge is discussed. Authored by experts in their respective fields, Management of Bladder Cancer will serve as a easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology. Badrinath R. Konety, MD, MBA, FACS Professor and Chair, Dept. of Urology Dougherty Family Chair in Urologic Oncology Associate Director for Clinical Affairs, Masonic Cancer Center University of Minnesota MMC 394, 420 Delaware St Minneapolis MN 55455, USA Sam S. Chang, MD, FACS Professor of Urologic Surgery Patricia and Rodes Hart Chair of Urologic Surgery Department of Urologic Surgery Vanderbilt University Medical Center MCN A 1302, VUMC Nashville, TN 37232, USA I. GENERAL CONCEPTS 1. Epidemiology and natural history Edward Messing and Emil Scosyrev 2. Screening for Bladder Cancer Laura-Maria Krabbe, Robert S. Svatek and Yair Lotan 3. Pathology and Staging: Histopathology and Cytopathology Amber Mackey, Farnaz Hasteh and Donna E. Hansel 4. Pathology and Staging: Genetics and Molecular Biology Sean McAdams and Michael C. Risk 5. Imaging in Localized and Advanced Bladder Cancer Timothy Kim, Joshua G. Griffin, Jeffrey M. Holzbeierlein and Wade J. Sexton 6. New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder Ramdev Konijeti and Adam S. Kibel 7. Socioeconomic issues and improved quality of care John L. Gore 8. Quality of life measures Christopher B. Anderson, David F. Penson and Daniel A. Barocas 9. Prognostication and risk assessment Luis Alex Kluth, Bernie Bochner and Shahrokh F. Shariat 10. Clinical trials and emerging therapeutic strategies in bladder cancer Richard M. Bambury, Robert B. Sims and Jonathan E. Rosenberg II. NON MUSCLE INVASIVE BLADDER CANCER 11. Improved diagnostic techniques Seth P. Lerner and Alvin C. Goh 12. Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging Christopher S. Gomez, Mark S. Soloway, Jorge Caso, Claudia P. Rojas and Merce Jorda 13. Localized surgical therapy and surveillance Manish I. Patel and Paul D. Sved 14. Clinical Scenario: Initial high grade Ta tumor Jose L. Dominguez-Escrig and Eduardo Solsona Narbón 15. Clinical Scenario: Recurrent Ta tumor Joseph A. Gillespie and Michael A. O'Donnell 16. Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor James S. Rosoff and Thomas A. Keane 17. Clinical Scenario: Low grade T1 tumor J. Alfred Witjes and Florine W.M. Schlatmann 18. Intravesical therapy Jennifer J. Ahn and James M. McKiernan 19. Clinical Scenario: Initial CIS Sima P. Porten and Colin P. Dinney 20. Management of BCG Recurrent Bladder Cancer Tracy M. Downs, Daniel J. Lee and Douglass S. Scherr 21. Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG Maurizio Brausi 22. Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation Donald L. Lamm and Nilay M. Gandhi 23. Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines Jeffrey C. Bassett, John D. Seigne and Peter E. Clark III. MUSCLE INVASIVE BLADDER CANCER 24. Open Radical Cystectomy J. Joy Lee, Dipen J. Parekh and Mark L. Gonzalgo 25. Robotic cystectomy Michael Woods, Raj Pruthi and Erik P. Castle 26. Clinical Scenario: T2 bladder tumor Richard E. Hautmann 27. Urinary Diversion: Open and robotic techniques Norm D. Smith, Gary D. Steinberg and Cheryl T. Lee 28. Chemoradiotherapy Christian Weiss and Claus Rödel 29. Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation Albert J. Chang, Maurice Marcel Garcia and Mack Roach III 30. Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application Gautam Jha, Guru Sonpavde and Zeeshan Ahmad 31. Clinical Scenario: Large volume, non metastatic T2 bladder tumor Chad R. Ritch and Michael S. Cookson 32. The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer Samuel D. Kaffenberger, Todd M. Morgan and Anne K. Schuckman 33. Clinical Scenario: Unexpected positive nodes at radical cystectomy Christian Thomas and Joachim W. Thüroff 34. Surveillance and monitoring Daniel J. Canter, Joseph Zabell, Stephen A. Boorjian and Christopher J. Weight 35. Clinical Scenario: The Role of Perioperative Chemotherapy Eila C. Skinner 36. Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy Adam C. Reese and Mark P. Schoenberg 37. Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU Amanda N. Calhoun and Kamal S. Pohar

Price: 190 AUD

Location: Hillsdale, NSW

End Time: 2025-02-04T17:46:15.000Z

Shipping Cost: 30.78 AUD